Literature DB >> 25373364

Non-secreting benign glucagonoma diagnosed incidentally in a patient with refractory thrombocytopenic thrombotic purpura: report of a case.

Georgios K Georgiou1, Ioannis Gizas2, Konstantinos P Katopodis3, Christos S Katsios2.   

Abstract

Thrombotic thrombocytopenic purpura (TTP) is a rare hematologic disorder, which may be idiopathic or secondary to a variety of diseases. However, there are very few reports of TTP in the context of pancreatic neoplasms. We report a case of relapsing TTP after initial treatment with plasmapheresis, corticosteroids, and rituximab, in a 59-year-old woman. During diagnostic work-up, a pancreatic lesion 35 × 25 mm in size was discovered incidentally and splenopancreatectomy was performed. The pathological diagnosis was benign glucagonoma. The hematological symptoms resolved completely after the procedure and 3 years later, the patient is well with no sign of recurrence of TTP or glucagonoma. To our knowledge, this represents the first documented case of a non-secreting benign pancreatic neuroendocrine tumor (glucagonoma) associated with TTP that is refractory to standard treatment.

Entities:  

Keywords:  Glucagonoma; Pancreatectomy; Plasmapheresis; Splenectomy; TTP

Mesh:

Substances:

Year:  2014        PMID: 25373364     DOI: 10.1007/s00595-014-1073-3

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  22 in total

1.  Metastatic pancreatic carcinoma presenting as thrombotic thrombocytopenic purpura.

Authors:  Daniel Wolff; Beate Brinkmann; Jörg Emmrich; Michael Steiner
Journal:  Pancreas       Date:  2003-04       Impact factor: 3.327

2.  Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura.

Authors:  Johanna A Kremer Hovinga; Jan-Dirk Studt; Franziska Demarmels Biasiutti; Max Solenthaler; Lorenzo Alberio; Caroline Zwicky; Stefano Fontana; Behrouz Mansouri Taleghani; Andreas Tobler; Bernhard Lämmle
Journal:  Haematologica       Date:  2004-03       Impact factor: 9.941

Review 3.  Thrombotic thrombocytopenic purpura: a hematological emergency.

Authors:  Chad S Kessler; Bilal A Khan; Katie Lai-Miller
Journal:  J Emerg Med       Date:  2012-03-24       Impact factor: 1.484

4.  Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura.

Authors:  J A Cohen; M E Brecher; N Bandarenko
Journal:  J Clin Apher       Date:  1998       Impact factor: 2.821

Review 5.  Glucagonomas and insulinomas.

Authors:  G Boden
Journal:  Gastroenterol Clin North Am       Date:  1989-12       Impact factor: 3.806

6.  Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years.

Authors:  Henrik Kindmark; Anders Sundin; Dan Granberg; Kristina Dunder; Britt Skogseid; Eva Tiensuu Janson; Staffan Welin; Kjell Oberg; Barbro Eriksson
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

Review 7.  Clinical experience in diagnosis and treatment of glucagonoma syndrome.

Authors:  Min Zhang; Xiao Xu; Yan Shen; Zhen-Hua Hu; Li-Ming Wu; Shu-Sen Zheng
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2004-08

Review 8.  Glucagonomas/diabetico-dermatogenic syndrome (DDS): a statistical evaluation of 407 reported cases.

Authors:  J Soga; Y Yakuwa
Journal:  J Hepatobiliary Pancreat Surg       Date:  1998

9.  Is glucagonoma of the pancreas a curable disease?

Authors:  Q D Chu; M F Al-kasspooles; J L Smith; H R Nava; H O Douglass; D Driscoll; J F Gibbs
Journal:  Int J Pancreatol       Date:  2001

10.  Recurrent thrombotic thrombocytopenic purpura-like syndrome as a paraneoplastic phenomenon in malignant peritoneal mesothelioma: a case report and review of the literature.

Authors:  Francisco Socola; Arturo Loaiza-Bonilla; Ernesto Bustinza-Linares; Ricardo Correa; Joseph D Rosenblatt
Journal:  Case Rep Oncol Med       Date:  2012-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.